326 related articles for article (PubMed ID: 9299613)
1. P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus.
Wang Y; Finan JE; Middeldorp JM; Hayward SD
Virology; 1997 Sep; 236(1):18-29. PubMed ID: 9299613
[TBL] [Abstract][Full Text] [Related]
2. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
Van Scoy S; Watakabe I; Krainer AR; Hearing J
Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
[TBL] [Abstract][Full Text] [Related]
3. Epstein-barr virus nuclear antigen-1 binds to nuclear transporter karyopherin alpha1/NPI-1 in addition to karyopherin alpha2/Rch1.
Ito S; Ikeda M; Kato N; Matsumoto A; Ishikawa Y; Kumakubo S; Yanagi K
Virology; 2000 Jan; 266(1):110-9. PubMed ID: 10612665
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus encoded nuclear protein EBNA-3 binds XAP-2, a protein associated with Hepatitis B virus X antigen.
Kashuba E; Kashuba V; Pokrovskaja K; Klein G; Szekely L
Oncogene; 2000 Mar; 19(14):1801-6. PubMed ID: 10777214
[TBL] [Abstract][Full Text] [Related]
5. The conserved domain CR2 of Epstein-Barr virus nuclear antigen leader protein is responsible not only for nuclear matrix association but also for nuclear localization.
Yokoyama A; Kawaguchi Y; Kitabayashi I; Ohki M; Hirai K
Virology; 2001 Jan; 279(2):401-13. PubMed ID: 11162796
[TBL] [Abstract][Full Text] [Related]
6. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines.
Kriauciunas KM; Goldstein BJ; Lipes MA; Kahn CR
J Cell Physiol; 1993 Mar; 154(3):486-95. PubMed ID: 8382208
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein.
Fukuma T; Enomoto N; Marumo F; Sato C
Hepatology; 1998 Oct; 28(4):1147-53. PubMed ID: 9755255
[TBL] [Abstract][Full Text] [Related]
8. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
9. An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha.
Kim AL; Maher M; Hayman JB; Ozer J; Zerby D; Yates JL; Lieberman PM
Virology; 1997 Dec; 239(2):340-51. PubMed ID: 9434725
[TBL] [Abstract][Full Text] [Related]
10. Delineation of a 16 amino acid sequence that forms a core DNA recognition motif in the Epstein-Barr virus EBNA-1 protein.
Chen MR; Zong J; Hayward SD
Virology; 1994 Dec; 205(2):486-95. PubMed ID: 7975250
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-encoded nuclear protein EBNA-3 interacts with the epsilon-subunit of the T-complex protein 1 chaperonin complex.
Kashuba E; Pokrovskaja K; Klein G; Szekely L
J Hum Virol; 1999; 2(1):33-7. PubMed ID: 10200597
[TBL] [Abstract][Full Text] [Related]
12. The Epstein-Barr virus nuclear antigen-6 protein co-localizes with EBNA-3 and survival of motor neurons protein.
Krauer KG; Buck M; Belzer DK; Flanagan J; Chojnowski GM; Sculley TB
Virology; 2004 Jan; 318(1):280-94. PubMed ID: 14972554
[TBL] [Abstract][Full Text] [Related]
13. Physical association between the EBV protein EBNA-1 and P32/TAP/hyaluronectin.
Chen MR; Yang JF; Wu CW; Middeldorp JM; Chen JY
J Biomed Sci; 1998; 5(3):173-9. PubMed ID: 9678487
[TBL] [Abstract][Full Text] [Related]
14. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter.
Le Roux A; Kerdiles B; Walls D; Dedieu JF; Perricaudet M
Virology; 1994 Dec; 205(2):596-602. PubMed ID: 7975264
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-encoded EBNA-5 binds to Epstein-Barr virus-induced Fte1/S3a protein.
Kashuba E; Yurchenko M; Szirak K; Stahl J; Klein G; Szekely L
Exp Cell Res; 2005 Feb; 303(1):47-55. PubMed ID: 15572026
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes.
McClain K; Estrov Z; Raju U; Kelley PK; Aggarwal BB
Methods; 1997 Jan; 11(1):83-7. PubMed ID: 8990093
[TBL] [Abstract][Full Text] [Related]
17. The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.
Tong X; Yalamanchili R; Harada S; Kieff E
J Virol; 1994 Oct; 68(10):6188-97. PubMed ID: 8083959
[TBL] [Abstract][Full Text] [Related]
18. The p542 gene encodes an autoantigen that cross-reacts with EBNA-1 of the Epstein Barr virus and which may be a heterogeneous nuclear ribonucleoprotein.
Rhodes GH; Valbracht JR; Nguyen MD; Vaughan JH
J Autoimmun; 1997 Oct; 10(5):447-54. PubMed ID: 9376072
[TBL] [Abstract][Full Text] [Related]
19. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
Ling PD; Hsieh JJ; Ruf IK; Rawlins DR; Hayward SD
J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
Cuomo L; Trivedi P; de Grazia U; Calogero A; D'Onofrio M; Yang W; Frati L; Faggioni A; Rymo L; Ragona G
J Med Virol; 1998 Jul; 55(3):219-26. PubMed ID: 9624610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
